TGen Drug Development   Report issue

Foundation Phase 1 Phase 2
Founded: Phoenix AZ United States (2003)

Organization Overview

First Clinical Trial
2007
NCT00528047
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

TGen Clinical Research Service at Scottsdale Healthcare | TGen Clinical Research Services at Scottsdale Healthcare | TGEN Clinical Research Services at Scottsdale Healthcare | Translational Genomics Research Institute | Translational Genomics Research Institute (TGen) An Affiliate of City of Hope